MULTIPLE MYELOMA (MM)
Clinical trials for MULTIPLE MYELOMA (MM) explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE MYELOMA (MM) trials appear
Sign up with your email to follow new studies for MULTIPLE MYELOMA (MM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Dual-Target attack: early trial tests new weapon against tough blood cancers
Disease control Recruiting nowThis early-phase study is testing the safety and initial effectiveness of a new cell therapy called OriV508 for adults with multiple myeloma or non-Hodgkin lymphoma that has returned or not responded to prior treatments. The therapy involves modifying a patient's own immune cells…
Matched conditions: MULTIPLE MYELOMA (MM)
Phase: EARLY_PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New hope for multiple myeloma patients: trial tests drug to keep cancer at bay longer
Disease control Recruiting nowThis study is testing whether adding a new drug called SCTC21C to a standard three-drug combination works better for controlling newly diagnosed multiple myeloma. It will involve about 292 patients who are not eligible for a stem cell transplant. The main goal is to see if the fo…
Matched conditions: MULTIPLE MYELOMA (MM)
Phase: PHASE3 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
T-Cell therapy challenges stem cell transplant in myeloma showdown
Disease control Recruiting nowThis study is testing if a new drug combination that activates the immune system can work as well as or better than a stem cell transplant for people newly diagnosed with multiple myeloma. About 100 participants will be randomly assigned to receive either the new drug therapy or …
Matched conditions: MULTIPLE MYELOMA (MM)
Phase: PHASE2 • Sponsor: SCRI Development Innovations, LLC • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
New hope for myeloma patients: testing a powerful drug duo
Disease control Recruiting nowThis study is testing the safety of a new two-drug combination for people with multiple myeloma that has come back or stopped responding to other treatments. About 60 participants will take a pill (cemsidomide) and receive an injection (elranatamab) to see how well they are toler…
Matched conditions: MULTIPLE MYELOMA (MM)
Phase: PHASE1 • Sponsor: C4 Therapeutics, Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC
-
Scientists hunt for clues to make cancer cell therapy last longer
Knowledge-focused Recruiting nowThis study aims to understand why some multiple myeloma patients respond better to CAR-T cell therapy than others. Researchers will track 60 patients receiving this advanced treatment, collecting blood and bone marrow samples over one year to identify immune markers that predict …
Matched conditions: MULTIPLE MYELOMA (MM)
Phase: NA • Sponsor: Poitiers University Hospital • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC